Kane RS - Search Results

1

Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization.

Chiba S, Frey SJ, Halfmann PJ, Kuroda M, Maemura T, Yang JE, Wright ER, Kawaoka Y, Kane RS. Chiba S, et al. Among authors: kane rs. Commun Biol. 2021 May 19;4(1):597. doi: 10.1038/s42003-021-02128-8. Commun Biol. 2021. PMID: 34011948 Free PMC article.

2

Bionanotechnology for vaccine design.

Frey S, Castro A, Arsiwala A, Kane RS. Frey S, et al. Among authors: kane rs. Curr Opin Biotechnol. 2018 Aug;52:80-88. doi: 10.1016/j.copbio.2018.03.003. Epub 2018 Mar 26. Curr Opin Biotechnol. 2018. PMID: 29597075 Free PMC article. Review.

3

Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery.

Arsiwala A, Castro A, Frey S, Stathos M, Kane RS. Arsiwala A, et al. Among authors: kane rs. Chem Asian J. 2019 Jan 18;14(2):244-255. doi: 10.1002/asia.201801677. Epub 2019 Jan 4. Chem Asian J. 2019. PMID: 30523672 Review.

4

One-pot synthesis of heterodimeric agonists that activate the canonical Wnt signaling pathway.

Mukherjee A, Stathos ME, Varner C, Arsiwala A, Frey S, Hu Y, Smalley DM, Schaffer DV, Kane RS. Mukherjee A, et al. Among authors: kane rs. Chem Commun (Camb). 2020 Mar 26;56(25):3685-3688. doi: 10.1039/d0cc00920b. Chem Commun (Camb). 2020. PMID: 32119023 Free PMC article.

5

The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen.

Frey SJ, Varner C, Arsiwala A, Currier MG, Moore ML, Kane RS. Frey SJ, et al. Among authors: kane rs. Adv Healthc Mater. 2021 Feb;10(4):e2000714. doi: 10.1002/adhm.202000714. Epub 2020 Aug 5. Adv Healthc Mater. 2021. PMID: 32755047

6

Potent neutralization of SARS-CoV-2 including variants of concern by vaccines presenting the receptor-binding domain multivalently from nanoscaffolds.

Halfmann PJ, Castro A, Loeffler K, Frey SJ, Chiba S, Kawaoka Y, Kane RS. Halfmann PJ, et al. Among authors: kane rs. Bioeng Transl Med. 2021 Sep 9;6(3):e10253. doi: 10.1002/btm2.10253. eCollection 2021 Sep. Bioeng Transl Med. 2021. PMID: 34589610 Free PMC article.

7

Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk-Directed Antibody Response.

Frey SJ, Carreño JM, Bielak D, Arsiwala A, Altomare CG, Varner C, Rosen-Cheriyan T, Bajic G, Krammer F, Kane RS. Frey SJ, et al. Among authors: kane rs. Adv Healthc Mater. 2023 May;12(13):e2202729. doi: 10.1002/adhm.202202729. Epub 2023 Feb 3. Adv Healthc Mater. 2023. PMID: 36689343 Free PMC article.

8

Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine.

Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Kawaoka Y, Kane RS. Halfmann PJ, et al. Among authors: kane rs. Res Sq [Preprint]. 2023 Jun 29:rs.3.rs-3088907. doi: 10.21203/rs.3.rs-3088907/v1. Res Sq. 2023. PMID: 37461652 Free PMC article. Updated. Preprint.

9

Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine.

Halfmann PJ, Loeffler K, Duffy A, Kuroda M, Yang JE, Wright ER, Kawaoka Y, Kane RS. Halfmann PJ, et al. Among authors: kane rs. Nat Commun. 2024 Feb 12;15(1):1284. doi: 10.1038/s41467-024-45495-6. Nat Commun. 2024. PMID: 38346966 Free PMC article.

10

Glycosylation as a tool for rational vaccine design.

Hariharan V, Kane RS. Hariharan V, et al. Among authors: kane rs. Biotechnol Bioeng. 2020 Aug;117(8):2556-2570. doi: 10.1002/bit.27361. Epub 2020 May 13. Biotechnol Bioeng. 2020. PMID: 32330286 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page